Related Experiment Video
Updated: Jul 5, 2025
09:31
Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
7.3K
Enhancing the Functionality of Immunoisolated Human SC-βeta Cell Clusters through Prior Resizing
Matthew A Bochenek1,2,3, Ben Walters1,2,3, Jingping Zhang4
1David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main Street, Cambridge, MA, 02139, USA.
Small (Weinheim an Der Bergstrasse, Germany)
|January 11, 2024
Summary
Smaller stem cell-derived beta cell clusters (SC-β) encapsulated in immunoisolation devices improve glucose control in diabetic mice. This approach minimizes fibrosis and enhances beta cell function, offering a promising strategy for type 1 diabetes treatment.
Area of Science:
- Biomedical Engineering
- Endocrinology
- Regenerative Medicine
Background:
- Type 1 diabetes management seeks alternatives to systemic immunosuppression.
- Stem cell-derived beta cell clusters (SC-β) offer a renewable source for diabetes therapy.
- Current SC-β transplantation faces challenges with revascularization and nutrient diffusion within immunoisolation devices.
Purpose of the Study:
- To investigate if smaller SC-β cell clusters improve function within immunoisolation devices.
- To assess the impact of cluster size on mass transport and graft performance.
- To evaluate the biocompatibility and anti-fibrotic properties of an A10 polycation coating.
Main Methods:
- SC-β cells were resized into smaller clusters (≈150 µm).
- Clusters were encapsulated in alginate spheres with an A10 polycation coating.
- Transplantation into diabetic immune-competent C57BL/6 mice.
- Assessment of glycemic control, fibrosis, and beta cell maturation markers post-transplantation.
Main Results:
- Transplanted smaller SC-β cells with A10 coating achieved long-term euglycemia (6 months) in mice.
- Resized SC-β cells showed reduced fibrosis compared to larger clusters.
- Enhanced markers of beta cell maturation were observed in the retrieved resized cells.
Conclusions:
- Utilizing smaller SC-β cell clusters within immunoprotection devices enhances therapeutic efficacy.
- The A10 polycation coating effectively resists fibrosis and supports beta cell function.
- This strategy holds significant potential for improving the clinical translation of beta cell replacement therapy for type 1 diabetes.
